NCT02886507View on ClinicalTrials.gov

Effects of NSK-SD (Nattokinase) on Blood Pressure

PHASE4CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Hypertension
Interventions
DIETARY_SUPPLEMENT

NSK-SD (nattokinase)

Nattokinase is a fibrinolytic enzyme from the fermented soy product natto. Encapsulated 100mg/capsule, excipient include microcrystalline cellulose.

DIETARY_SUPPLEMENT

Placebo

The placebo capsules contain microcrystalline cellulose.

All Listed Sponsors
collaborator

JBSL-USA Incorporated

INDUSTRY

lead

Natural Immune Systems Inc

OTHER

NCT02886507 - Effects of NSK-SD (Nattokinase) on Blood Pressure | Biotech Hunter | Biotech Hunter